What are the differences between a urachal cyst and a patent urachus in terms of anatomy, clinical presentation, diagnostic evaluation, and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urachal Cyst vs Patent Urachus: Key Differences

Anatomic Distinctions

A urachal cyst is a closed, fluid-filled cavity located in the midline lower abdominal wall that does not communicate with either the umbilicus or bladder, while a patent urachus is a persistent tubular connection extending from the anterosuperior bladder to the umbilicus. 1

  • Urachal cyst: Appears as a noncommunicating, fluid-filled cavity positioned just beneath the umbilicus or above the bladder in the midline anterior abdominal wall 1
  • Patent urachus: Demonstrates complete tubular patency connecting the bladder dome to the umbilicus, representing failure of complete obliteration during fetal development 1
  • Other urachal remnants include umbilical-urachal sinus (blind-ending tract at umbilical end) and vesicourachal diverticulum (outpouching at bladder end) 1

Clinical Presentation Patterns

The clinical presentations differ markedly: patent urachus typically presents with periumbilical drainage (54% of cases), while urachal cysts present with periumbilical pain (30%) or palpable mass (22%). 2

Patent Urachus:

  • Continuous umbilical drainage or "wet umbilicus" is pathognomonic 3, 4
  • May be diagnosed prenatally on routine ultrasound screening 4
  • Symptoms present earlier in life, often in infancy 4

Urachal Cyst:

  • Periumbilical or lower abdominal pain when infected 3, 2
  • Palpable midline abdominal mass 3, 2
  • Fever and pyuria when complicated by infection 3
  • Can achieve massive size with stone formation in rare cases 3
  • Often presents later in childhood or adulthood 4

Diagnostic Evaluation Algorithm

For periumbilical drainage, perform a sinogram (100% diagnostic for patent urachus); for periumbilical mass, perform ultrasound (82-100% diagnostic for urachal cyst). 4, 2

First-Line Imaging by Presentation:

Periumbilical drainage:

  • Sinogram is diagnostic in 100% of patent urachus cases 4
  • Voiding cystourethrogram (VCUG) is diagnostic in 100% of patent urachus but only 6% of sinuses 4

Periumbilical mass or pain:

  • Ultrasound is diagnostic in 82-100% of urachal cysts 4, 2
  • High-frequency ultrasound shows anechoic structure along the urachus for cysts 5
  • Patent urachus appears as tubular connection between umbilicus and bladder on longitudinal ultrasound 1

Second-Line Imaging:

  • CT scan correctly diagnoses 71% of urachal cysts when ultrasound is inconclusive 2
  • CT shows midline cystic lesion just above the anterosuperior bladder 1
  • VCUG has limited utility for cysts (only 6-13% diagnostic) 4

Critical Diagnostic Pitfall:

  • Physical examination alone can be diagnostic in many cases; avoid unnecessary imaging when clinical diagnosis is clear 2
  • Infected urachal cysts and urachal carcinoma appear similar on imaging (thick-walled, increased echogenicity), requiring percutaneous biopsy for differentiation 1

Management Approach

Complete surgical excision with bladder cuff resection is the definitive treatment for all urachal remnants in adults to prevent recurrent infection and malignant transformation. 6

Surgical Technique:

  • En-bloc resection of the entire urachal ligament with umbilicus and bladder cuff excision is recommended for all symptomatic or discovered urachal remnants 6
  • For patent urachus: Excision of urachal tract with bladder dome resection 3, 4
  • For urachal cyst: Excision with bladder cuff in 50% of cases, or excision without bladder cuff in 50% 4
  • Laparoscopic excision is an acceptable alternative approach 4

Critical Management Pitfall:

  • Incomplete excision must be avoided, as retained urachal remnants carry risk of malignant transformation 6
  • Wound infection occurs in 7-9% of cases postoperatively 4, 2
  • Simple incision and drainage of infected cysts is inadequate definitive treatment 4

Timing Considerations:

  • Infected cysts may require initial drainage followed by delayed definitive excision after inflammation resolves 3
  • All urachal remnants warrant complete excision even if asymptomatic, given malignancy risk 6

References

Research

Urachal remnant diseases: spectrum of CT and US findings.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2001

Research

A diagnostic algorithm for urachal anomalies.

Journal of pediatric urology, 2007

Research

Urachal anomalies: acquired patent urachus and giant urachal cyst--2 cases report.

Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences, 1990

Guideline

Treatment of Urachal Cyst

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best investigation for umbilical discharge, Magnetic Resonance Imaging (MRI) or Ultrasound (US)?
What is the recommended follow-up assessment for a 43-year-old female 2 months after urachal cyst excision and hernia repair?
Can a urachal anomaly cause recurrent urinary tract infections?
What is the next step for a suspected urachal remnant anterior to the bladder border?
What are the implications of a hypoechoic region in the left anterior bladder wall suggestive of a urachal remnant?
What is the appropriate treatment for a 1-year-old child who develops localized edema and erythema at the injection site after receiving the hexacima (hexavalent) vaccine?
What are the recommended diagnostic and therapeutic approaches for heart failure with reduced ejection fraction (EF < 40%) versus heart failure with preserved ejection fraction (EF ≥ 50%)?
Should intravenous isotonic saline be administered to every patient meeting sepsis criteria, or are there contraindications such as severe heart failure, end‑stage renal disease on dialysis, or known fluid overload?
What are the next steps to evaluate and manage a hospitalized patient who remains constipated after receiving an appropriate dose of polyethylene glycol (Miralax) and an enema?
How can digital technology be safely and effectively incorporated into pulmonary rehabilitation for adults with chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma, interstitial lung disease, and post‑COVID‑19 sequelae?
What is the recommended evaluation and management for a patient with enlarged lymph nodes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.